Connect with us

Healthcare

Poll: Most voters think COVID-19 likely came from Chinese lab

Published

on

coronavirus covid 19

According to the most recent Rasmussen poll, most likely American voters agree that the origin of the COVID-19 virus is suspicious enough that it should be investigated. A majority also suspects it came straight from a Chinese laboratory.

53% of respondents believe it is “very important” for authorities to investigate the virus’s origins. Meanwhile, 29% responded it was “somewhat important” to do so. Ages 65+ had the highest majority that was for an investigation, then the 40-64 age group, then the 18-39 age group. This comes the day after President Biden announced that he “asked the Intelligence Community to redouble their efforts to collect and analyze information that could bring us closer to a definitive conclusion,” according to a statement. Biden demanded a report within 90 days.

Further, 43% believed it was very likely that it originated from a Chinese lab. Reports have claimed that staffers from the Wuhan Virology Instituted came down with COVID-like symptoms as early as November 2019.

See the findings here.

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

You may like

Continue Reading

Healthcare

TN Republican introduces legislation to fight opioid shipments into U.S.

Published

on

Fentanyl 1031234188 scaled

Tennessee Republican Representative Diana Harshbarger is attempting to fight the opioid crisis and epidemic through new legislation. Introduced Friday, Harshbarger told the Daily Caller:

The Daily Caller first obtained a copy of the legislation, which addresses what Harshbarger calls a “loophole.” The legislation amends the Controlled Substances Act to specifically require registrants to investigate reports of suspicious orders of controlled substances and halt them if necessary. Under the version of the act currently in force, drug manufacturers and distributors are only required to report suspicious orders of opioids and other controlled substances to the DEA.

“Breaking the opioid epidemic’s stranglehold on our nation is one of my foremost priorities. In an effort to do so, my colleagues and I have identified a loophole that allows distributors to continue order fulfillment, even under suspicious circumstances.”

“My bill closes that loophole with the requirements and guardrails needed to ensure these addictive and potentially dangerous drugs do not fall into the wrong hands while the DEA investigates. The future of our nation depends on us solving the addiction crisis, and this is a step towards that outcome” Harshbarger continued.

The Daily Caller reports:

According to a congressional report released in September, the opioid crisis cost the U.S. $1.5 trillion during the COVID-19 pandemic.

The CDC says 93,331 people died from overdoses in the U.S. in 2020, the highest in 50 years. Opioid-related deaths made up nearly three-quarters of the total.

Pharmaceutical companies have been blamed for contributing to the opioid epidemic. The Department of Justice is currently suing the pharmaceutical company AmerisourceBergen over allegations the company failed to report suspicious orders of opioids to federal law enforcement.

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC